Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of New Candidate Vaccine Antigens Made byStreptococcus pyogenes:Purification and Characterization of 16 Putative Extracellular Lipoproteins

1 Jan 2004

Abstract excerpt

Putative extracellular lipoproteins made by group A Streptococcus (GAS) are the focus of this study, which was designed to identify new candidate vaccine antigens. Bioinformatic analysis of a serotype M1 GAS strain identified 30 open-reading frames encoding putative lipoproteins. The genes encoding the mature form of 29 of these proteins were cloned, and 16 recombinant proteins were overexpressed in Escherichia...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimicrobial Resistance in Staphylococcus
Share to Neonatal and Maternal Infections
Share to Streptococcal Infections and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 14702157
DOI: 10.1086/380491

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of New Candidate Vaccine Antigens Made byStreptococcus pyogenes:Purification and Characterization of 16 Putative Extracellular LipoproteinsPMID 14702157Read ↗

Novel Conserved Group A Streptococcal Proteins Identified by the Antigenome Technology as Vaccine Candidates for a Non-M Protein-Based VaccineSemantic proximity Read ↗

Use of a Whole Genome Approach To Identify Vaccine Molecules Affording Protection against Streptococcus pneumoniae InfectionSemantic proximity Read ↗

Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines?Semantic proximity Read ↗

Pneumococcal Surface Proteins as Virulence Factors, Immunogens, and Conserved Vaccine TargetsSemantic proximity Read ↗

Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococciSemantic proximity Read ↗

Molecular biology of Group A Streptococcus and its implications in vaccine strategies.Semantic proximity Read ↗

Current status and perspectives on protein-based pneumococcal vaccinesSemantic proximity Read ↗

Update on the development of Group A Streptococcus vaccinesSemantic proximity Read ↗

Reverse and structural vaccinology approach to design a highly immunogenic multi-epitope subunit vaccine against Streptococcus pneumoniae infection.Semantic proximity Read ↗

A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for Molecular Typing and Vaccine DevelopmentSemantic proximity Read ↗

Progress toward a group B streptococcal vaccineSemantic proximity Read ↗

The Human Pathogen Streptococcus pyogenes Releases Lipoproteins as Lipoprotein-rich Membrane Vesicles.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.